News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
133 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17551)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Policy
Repros Announces Negative Opinion From the EMA for Enclomiphene
The CHMP has formally issued a negative opinion for the centralized MAA for enclomiphene for the treatment of secondary hypogonadism previously submitted to the EMA by the Company’s U.K. subsidiary, Renable Pharma. Limited.
January 29, 2018
·
4 min read
Tigenix: Transparency Notifications Pursuant to Article 14 of the Law of May 2, 2007 – Jan. 29, 2018
It concerns the following four transparency notifications received from Bank of America Corporation.
January 29, 2018
·
10 min read
Business
IntelGenx Mourns the Passing of Long Term Director Ian Troup
Mr. Troup has been a Director of IntelGenx since November of 2008.
January 29, 2018
·
1 min read
Business
Arjo Year-End Report January-December 2017
Net sales fell -4.9% to SEK 2,068 M.
January 29, 2018
·
3 min read
Ossur Hf : Transactions in Relation to Share Buyback Program - Jan. 29, 2018
On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017.
January 29, 2018
·
2 min read
Business
STORM Therapeutics Appoints Distinguished Professor and Nobel Prize Winner Professor Thomas Cech as Scientific Advisor
This appointment follows STORM Therapeutics’ successful Series A Financing Extension announced in January 2018.
January 29, 2018
·
2 min read
SBRI Healthcare Alumni Company Owlstone Medical Wins Global IPF Catalyst Challenge
SBRI Healthcare is delighted to congratulate Owlstone Medical on being named one of three winners of the global Idiopathic Pulmonary Fibrosis Catalyst Challenge.
January 29, 2018
·
2 min read
Genetown
Waters BioResolve RP mAb Polyphenyl Columns, Setting a New Standard for Reversed-Phase Separations of Monoclonal Antibodies and Antibody Drug Conjugates
Waters Corporation today introduced BioResolve RP mAb Polyphenyl 450 angstrom 2.7 micron solid core Columns intended for the reversed-phase analysis of intact or sub-unit-digested monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) using LC-UV and LC-MS.
January 29, 2018
·
5 min read
Biotech Beach
UC Santa Cruz Release: Breakthrough Leads to Sequencing of a Human Genome Using a Pocket-Sized Device
Using a pocket-sized, portable DNA sequencer based on nanopore sequencing technology pioneered at UC Santa Cruz, the scientists sequenced a complete human genome, in fragments hundreds of times larger than usual, enabling new biological insights.
January 29, 2018
·
5 min read
Biotech Bay
Audentes Therapeutics Announces the Closing of its Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
BofA Merrill Lynch, Cowen and Leerink Partners are acting as joint book-running managers for the offering.
January 29, 2018
·
3 min read
Previous
5 of 14
Next